Back to search
Post-ERCP Bleeding
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Post-ERCP Bleeding trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Post-ERCP Bleeding trials you may qualify forBackground and Aim: Endoscopic retrograde cholangiopancreatography (ERCP) and sphincterotomy (EST) are standard treatments for choledocholithiasis. However, 10%…
Bleeding is the most frequently reported serious complication of endoscopic sphincterotomy, and severe bleeding has occurred in about 1% to 2% of patients. Endo…
The incidence of bleeding during ERCP and following ERCP has been estimated using retrospective sources, but granular predictors of bleeding remain unknown, inc…
The aim of this observational study is to evaluate safety and efficacy of a novel self-assembling peptide hemostatic gel in reduction of bleeding after endoscop…
Post sphinterotomy-bleeding (PSB) occurs in 1-2 % of Endosocpic Retrograde Cholangiopancreaticography (ERCP) and usually needs no blood transfusion after endosc…